Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,280.00
Bid: 3,280.00
Ask: 3,300.00
Change: -25.00 (-0.76%)
Spread: 20.00 (0.61%)
Open: 3,245.00
High: 3,330.00
Low: 3,245.00
Prev. Close: 3,305.00
RHIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Secondary Placing in RHI Magnesita N.V.

9 Jul 2019 07:00

RNS Number : 8689E
Jefferies International Limited.
09 July 2019
 

 

 

 

 

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH ITS DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT IS NOT A PROSPECTUS AND DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE THE SECURITIES REFERRED TO HEREIN IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL.

PRESS RELEASE

 

09 July 2019

 

Results of placing of ordinary shares in the form of existing depositary interests in RHI Magnesita N.V.

 

Further to the announcement released on 08 July 2019 in relation to a proposed placing of ordinary shares in RHI Magnesita N.V. ("RHI Magnesita") in the form of depositary interests (each depositary receipt representing one ordinary share), funds managed by GP Investments Ltd. ("GP Investments") announce that they have sold 2,156,794 ordinary shares (the "Placing Shares") in RHI Magnesita, representing approximately 4.36% of RHI Magnesita's entire issued share capital at a price of 4,600 pence per depositary interest (the "Transaction").

 

After completion of the Placing, GP Investments will hold approximately 4.36% of the issued share capital of RHI Magnesita.

 

Jefferies acted as sole global coordinator and sole bookrunner on the Transaction. N. M. Rothschild & Sons Limited ("Rothschild & Co") acted as the sole financial adviser to GP Investments on the Transaction

 

RHI Magnesita will not receive any proceeds from the Transaction.

 

 

Enquiries:

Jefferies (Sole Global Coordinator and Sole Bookrunner) +44 (0)20 7029 8000

Luca Erpici / Oliver Berwin/ Laurene Danon

IMPORTANT NOTICE

This announcement is for information purposes only and shall not constitute or form part of an offer to buy, sell, issue, acquire or subscribe for, or the solicitation of an offer to buy, sell, issue, acquire or subscribe for any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

The distribution of this announcement and the offer and sale of the securities referred to herein may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. The offer and sale of securities referred to herein has not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration under the Securities Act, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada, Japan or South Africa and, subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada, Japan or South Africa. There will be no public offer of the securities in the United States, Australia, Canada, Japan, South Africa or any other jurisdiction.

In member states of the European Economic Area which have implemented the Prospectus Directive (each, a "Relevant Member State"), this announcement and any offer if made subsequently is directed exclusively at persons who are "qualified investors" within the meaning of the Prospectus Directive ("Qualified Investors"). For these purposes, the expression "Prospectus Directive" means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression "2010 PD Amending Directive" means Directive 2010/73/EU. In the United Kingdom, this announcement is directed exclusively at Qualified Investors: (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"); or (ii) who fall within Article 49(2)(A) to (D) of the Order; or (iii) to whom it may otherwise lawfully be communicated.

No prospectus or offering document has been or will be prepared in connection with the Transaction. Any investment decision to buy securities in the Transaction must be made solely on the basis of publicly available information. Such information is not the responsibility of and has not been independently verified by any of GP Investments, Jefferies, Rothschild & Co and/or any of their respective affiliates.

This announcement does not represent the announcement of a definitive agreement to proceed with the Transaction and, accordingly, there can be no certainty that the Transaction will proceed.

Jefferies, which is authorised and regulated by Financial Conduct Authority in the United Kingdom, is acting exclusively for GP Investments and no-one else in connection with the offering. Jefferies will not regard any other person as its clients in relation to the offering and will not be responsible to anyone other than GP Investments for providing the protections afforded to its clients, nor for providing advice in relation to the offering, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

Rothschild & Co, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom, is acting for GP Investments and no-one else in connection with the Transaction. Rothschild & Co will not regard any other person as its client(s) in relation to the Transaction and will not be responsible to any person(s) other than GP Investments for providing protections afforded to clients of Rothschild & Co nor for providing financial advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

In connection with any offering of the securities, each of Jefferies and any of its respective affiliates acting as an investor for their own account may take up as a proprietary position any securities and in that capacity may retain, purchase or sell for their own accounts such securities. In addition they may enter into financing arrangements and swaps with investors in connection with which they may from time to time acquire, hold or dispose of securities. They do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.

None of Jefferies, Rothschild & Co, nor any of their respective directors, officers, employees, affiliates, alliance partners, advisers and/or agents accepts any responsibility or liability whatsoever for or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from this announcement) or any other information relating to RHI Magnesita N.V. or GP Investments or any of their respective subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCMMGGNZRRGLZZ
Date   Source Headline
2nd Apr 20241:16 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSAcquisition of Resco Group
21st Mar 20249:03 amRNSNotice of AGM
8th Mar 20249:29 amRNSDirector/PDMR Shareholding
28th Feb 202411:50 amRNS2023 Full Year Results
1st Feb 20247:46 amRNSTotal Voting Rights
31st Jan 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
1st Dec 20239:02 amRNSTotal Voting Rights
1st Dec 20238:39 amRNSNotification of major shareholding
31st Oct 20237:00 amRNSQ3 2023 Trading Update
16th Oct 20237:00 amRNSNotification of major shareholding
3rd Oct 20237:00 amRNSAcquisition of P-D Refractories
26th Sep 202311:00 amRNSDirector Nomination
1st Sep 20237:00 amRNSTotal Voting Rights
28th Jul 202310:55 amRNSNotification of major shareholding
27th Jul 20233:47 pmRNSNotification of major shareholding
26th Jul 20237:00 amRNSRHI Magnesita half-year results
19th Jul 20233:36 pmRNSNotice of Results
10th Jul 20235:31 pmRNSResponse to partial offer extension
3rd Jul 202311:48 amRNSTotal Voting Rights
27th Jun 20238:53 amRNSResponse to partial offer
19th Jun 20233:20 pmRNSNotification of major shareholding
16th Jun 20237:00 amRNSTotal Voting Rights
16th Jun 20237:00 amRNSReplacement: Exercise of LTIP Options by PDMRs
15th Jun 20237:00 amRNSTrading Update
31st May 20231:40 pmRNSExercise of LTIP Options by PDMRs
30th May 202311:04 amRNSResponse to intended partial cash offer
24th May 20234:10 pmRNSResult of AGM 2023
5th May 20237:00 amRNSQ1 2023 Trading Update
21st Apr 20234:11 pmRNSAcquisition of Seven Refractories
13th Apr 20237:00 amRNSDebt financing update
12th Apr 20237:00 amRNSRHI Magnesita - Notice of AGM 2023
5th Apr 20235:00 pmRNSIndian subsidiary equity issuance
29th Mar 20234:47 pmRNSIndian subsidiary equity issuance
29th Mar 20237:00 amRNSAcquisition of Dalmia GSB Refractories GmbH
6th Mar 20235:39 pmRNS2023 Long Term Incentive Plan Awards
27th Feb 20237:00 amRNS2022 Full Year Results
20th Feb 20237:00 amRNSNotice of Results
13th Jan 20237:00 amRNSAcquisition of Jinan New Emei
11th Jan 20233:44 pmRNSNotification of major shareholding
1st Dec 20227:00 amRNSTotal Voting Rights
29th Nov 202212:57 pmRNSDirector/PDMR Shareholding
21st Nov 20227:00 amRNSAcquisition of Dalmia Bharat Refractories Limited
8th Nov 20222:00 pmRNSDirector/PDMR Shareholding
7th Nov 20223:49 pmRNSDirector/PDMR Shareholding
19th Oct 20227:00 amRNSEarnings on track for full year expectations
17th Oct 20224:29 pmRNSDirectorate Change
1st Aug 20227:00 amRNSRHI Magnesita half-year results
22nd Jul 20222:00 pmRNSNotice of 2022 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.